Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis

Author:

Šink Roman1,Sosič Izidor1,Živec Matej1,Fernandez-Menendez Raquel2,Turk Samo1,Pajk Stane1,Alvarez-Gomez Daniel2,Lopez-Roman Eva Maria2,Gonzales-Cortez Carolina2,Rullas-Triconado Joaquin2,Angulo-Barturen Inigo2,Barros David2,Ballell-Pages Lluís2,Young Robert J.3,Encinas Lourdes2,Gobec Stanislav1

Affiliation:

1. Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenija

2. Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain

3. Medicines Research Centre, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.

Funder

European Commission

Global Alliance for TB Drug Development

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference48 articles.

1. WHO Global Tuberculosis Report 2014;World Health Organization:Geneva, 2014; http://www.who.int/tb/publications/global_report/en/(accessed February 11, 2014).

2. Advancing the development of tuberculosis therapy

3. Extensively drug-resistant tuberculosis: current challenges and threats

4. Global Tuberculosis Report 2013;World Health Organization:Geneva, 2013; http://www.who.int/tb/publications/factsheet_global.pdf(accessed on February 11, 2014).

5. Totally Drug-Resistant Tuberculosis in India

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3